Bank of Nova Scotia Trust’s West Pharmaceutical WST Stock Holding History

Bank of Nova Scotia Trust’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-24	Closed	-$2K	–	403
2017 Q3	$2K	Buy	+24	New	+$2.17K	﹤0.01%	434

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of Nova Scotia Trust's WST Position: Q4 2017 in Review

Bank of Nova Scotia Trust sold out of West Pharmaceutical (WST) in Q4 2017, closing a stake of 24 shares — an estimated $2K sold.

Bank of Nova Scotia Trust first reported a position in WST in Q3 2017 and held it in 1 quarter. The position peaked at $2K in Q3 2017. 338 funds tracked by Wall St. Rank hold WST as of Q4 2017.

Bank of Nova Scotia Trust reported no remaining West Pharmaceutical position as of Q4 2017 after selling out during the quarter.
Bank of Nova Scotia Trust sold 24 West Pharmaceutical shares in Q4 2017, an estimated $2K.
Bank of Nova Scotia Trust first reported a position in West Pharmaceutical in Q3 2017 and held it in 1 quarter.
Bank of Nova Scotia Trust's West Pharmaceutical position peaked at $2K in Q3 2017.
338 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2017.

Based on Bank of Nova Scotia Trust's 13F filing for Q4 2017, filed 13 Feb 2018.